You are using an outdated browser. Please upgrade your browser to improve your experience.

aldesleukin

Ligand Summary
Description
a recombinant human IL-2, marketed for the treatment of metastatic renal cell carcinoma; BAY 50-4798 is a variant
Synonyms & Links
DrugCentral: 5011
LyCHI:  aldesleukin


Target Activities